George W. LeMaitre - Dec 11, 2021 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role: Chairman and CEO, Director, 10%+ Owner
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Stock symbol: LMAT
Transactions as of: Dec 11, 2021
Transactions value $: $274,979
Form type: 4
Date filed: 12/14/2021, 03:11 PM
Previous filing: Dec 6, 2021
Next filing: Mar 28, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LMAT	Common Stock	Award	$275K	+5.66K	+0.22%	$48.60	2.53M	Dec 11, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LMAT	Stock Option (Right to Buy)	Award	$0	+30.9K		$0.00	30.9K	Dec 11, 2021	Common Stock	30.9K	$48.60	Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.
F2	The exercise price of this option to the extent it is an incentive stock option (if at all) is $53.46 per share, and the exercise price of this option to the extent it is a nonqualified stock option is $48.60 per share.
F3	This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.
F4	The expiration date of this option to the extent it is an incentive stock option (if at all) is 12/11/2026, and the expiration date of this option to the extent it is a nonqualified stock option is 12/11/2028.